Drug news
FDA approves M2 Compact MRI (Aspect Imaging) for wrist Imaging
The FDA has cleared the M2 Compact MRI system, from Aspect Imaging, for diagnostic Imaging of the wrist. Unlike conventional high field MRI systems, the M2 Compact Wrist System does not require a shielded room, cryogens, or high capacity electrical power. The system features an innovative 1 Tesla, self-shielded, permanent magnet operating in a quiet manner. As a result, the compact MRI can be placed in most clinical settings as it does not require special infrastructure. This allows siting flexibility for clinicians and providers, with marginal site preparation costs.
The Company expects to begin commercialization of the instrument in the summer of 2013 and plans to run clinical studies at multiple sites in the US.